Seroprevalence of viral transfusion transmissible infections (HBsAg, anti-HCV, anti-HIV, Syphilis) and coinfection among healthy volunteer blood donors during 5-years in Luanda, Angola✰

Seroprevalence of viral transfusion transmissible infections (HBsAg, anti-HCV, anti-HIV, Syphilis) and coinfection among healthy volunteer blood donors during 5-years in Luanda, Angola✰

Background: The transmission of diseases by blood products continues to be a worldwide health problem, especially in Africa. Seroprevalence rates of the Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human Immunodeficiency Virus (HIV), Syphilis, and Coinfection in Angola are poorly documented. Th...

Full description

Bibliographic Details
Main Authors:	Angelina Edna Quintas, Cláudia Camila Dias, Adis Del Carmen Cogle, Lemuel Cordeiro, António Sarmento
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Transfusion-transmissible infection Seroprevalence Blood donors África
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867023009649

Similar Items

Seroprevalence of HBsAg, Anti-HBs, anti-HDV and HDVAg in Inonu University Medical Faculty Hospital, 2012 [Inonu Universitesi Tip Fakultesi Hastanesinde, 2012 Yilinda, HBsAg, Anti-HBs, Anti-HDV ve HDVAg Seroprevalansi]
by: Yucel Duman, et al.
Published: (2014-03-01)

HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
by: Imme Roggenbach, et al.
Published: (2021-09-01)

Kan vericilerde HBsAg, anti-HCV, anti-HIV ve Sifilis seroprevalansı
by: Mustafa Altındiş, et al.
Published: (2011-03-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

Concurrent presence of HBsAg and anti-HBs in children
by: H Ozen, et al.
Published: (2000-07-01)

Seroprevalence of Hepatitis B virus surface antigen among African blood donors: a systematic review and meta-analysis
by: Angelina Edna Quintas, et al.
Published: (2024-10-01)

Prevalências do HBsAg, do anti-HBc e do anti-HCV na população de candidatos a doadores de sangue do Hemocentro-Campinas Prevalence of HBsAg, anti-HBc and anti-HCV in the blood donors of "Hemocentro-Campinas"
by: Fernando Lopes Gonçales Júnior, et al.
Published: (1993-02-01)

Seroprevalence Study of Anti-HBs Antibodies in the General Population of Vojvodina, Serbia
by: Smiljana Rajčević, et al.
Published: (2024-03-01)

Seroprevalence of Hepatitis B Virus Surface Antigen (HBsAg) Positivity in KAHS Teaching Hospital, Jumla
by: Bibek Pun Magar, et al.
Published: (2020-12-01)

Seroprevalence of Hepatitis B Virus Surface Antigen (HBsAg) Positivity in KAHS Teaching Hospital, Jumla
by: Bibek Pun Magar, et al.
Published: (2020-12-01)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
by: Carlotta Cerva, et al.
Published: (2022-02-01)

HBsAg Loss Due to Tenofovir Treatment for HBV Reactivation Following DAAs Therapy in One Patient with HBV-HCV Coinfection
by: Dan-Dan He, et al.
Published: (2021-07-01)

Anti-HBs Seroprevalence in Blood Donors from Tyrol, Austria
by: Lisa Seekircher, et al.
Published: (2024-10-01)

Frequency of HbsAg and Anti-HCV among Hemodialysis Patients in three Genral Hospitals of Azad Jammu and Kashmir State
by: Ghayas Ud Din Dar, et al.
Published: (2020-01-01)

ORIGINAL ARTICLE: Blood Donors Status of HIV, HBV, HCV and Syphilis in this Region of Marathwada, India
by: Rangrao H. Deshpande, et al.
Published: (2012-07-01)

Evaluation of the dried blood spot (DBS) collection method as a tool for detection of HIV Ag/Ab, HBsAg, anti-HBs and anti-HCV in a Malaysian tertiary referral hospital
by: Lee, C.E., et al.
Published: (2011)

Seroconversion among children with HBsAg-positive mothers in Indonesia and factors affecting the anti-HBs titers
by: Angga Wirahmadi, et al.
Published: (2024-06-01)

Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy
by: Muye Xia, et al.
Published: (2025-02-01)

Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients
by: Hui Liu, et al.
Published: (2024-04-01)

Role of HBsAg Neutralisation Test in Low Positive and Indeterminate HBsAg Results by Electrochemiluminescence
by: Mridula Madiyal, et al.
Published: (2024-03-01)

Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients
Published: (2011-12-01)

Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low resource setting
by: Shreyasi Athalye, et al.
Published: (2024-02-01)

Preoperative Hepatitis B seroprevalence and AntiHbs Levels in Children Consulted for Dental Procedures Under Anaesthesia
by: Fatma Kaya, et al.
Published: (2024-04-01)

Comparative analysis of the safety and efficacy of HBsAg-1018 versus HBsAg-Eng: a meta-analysis
by: Lin Zhang, et al.
Published: (2020-01-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
by: Taqwa Hashim, et al.
Published: (2023-12-01)

HBV, HCV and HIV Seroprevalence in Soldiers Tested for Carriership
by: Ozcan Deveci, et al.
Published: (2014-06-01)

Frequency of HBsAg variants in occult hepatitis B virus infected patients and detection by ARCHITECT HBsAg quantitative
by: Chengshan He, et al.
Published: (2024-05-01)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
by: Shaowen Jiang, et al.
Published: (2023-01-01)

Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders
by: Kana Shiraishi, et al.
Published: (2023-09-01)

T-Cell Receptor β Chain and B-Cell Receptor Repertoires in Chronic Hepatitis B Patients with Coexisting HBsAg and Anti-HBs
by: Qiao Zhan, et al.
Published: (2022-06-01)

Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access Immunoassay Analyzer
by: Benoit Visseaux, et al.
Published: (2024-03-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Geographic distribution of HBsAg subtypes in Brazil Distribuição geográfica dos subtipos de antígenos de HBsAg no Brasil
by: Ana Maria Coimbra Gaspar, et al.
Published: (1987-06-01)

Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States
by: Mukarram Jamat Ali, et al.
Published: (2024-04-01)

Clinical Features Related to Severity and Mortality among COVID-19 Patients in a Pre-Vaccine Period in Luanda, Angola
by: Cruz S. Sebastião, et al.
Published: (2022-10-01)

Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg
by: Silvia Meschi, et al.
Published: (2024-03-01)

Factors influencing access to primary health care in Luanda, Angola
by: Antónia Sónia de Carvalho Maquengo, et al.
Published: (2025-02-01)

Assessment of Lean Maturity Levels in Industries of the Luanda Region, Angola
by: Agostinho Alberto, et al.
Published: (2024-08-01)

Epidemiology and molecular characterization of hepatitis B virus in Luanda, Angola
by: Fatima Valente, et al.
Published: (2010-12-01)

Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation
by: Yandi Xie, et al.
Published: (2023-06-01)